Excitation-contraction and excitation-transcription coupling in atrial fibrillation

ISRCTN ISRCTN05515812
DOI https://doi.org/10.1186/ISRCTN05515812
Secondary identifying numbers MEC 10-2-004
Submission date
28/05/2010
Registration date
10/02/2011
Last edited
29/05/2020
Recruitment status
No longer recruiting
Overall study status
Completed
Condition category
Circulatory System
Prospectively registered
Protocol
Statistical analysis plan
Results
Individual participant data
Record updated in last year

Plain English summary of protocol

Not provided at time of registration

Contact information

Dr Benoit-Gilles Kerfant
Scientific

Maastricht University
Cardiovascular Research Institute Maastricht (CARIM)
Department of Physiology
Universiteitssingel 50, Room 3.112
PO Box 616
Maastricht
6200 MD
Netherlands

Study information

Study designInterventional open study
Primary study designInterventional
Secondary study designNon randomised controlled trial
Study setting(s)Hospital
Study typeTreatment
Scientific titleCalcium role in the excitation-contraction and excitation-transcription coupling processes in human atrial fibrillation
Study objectives1. Reduction of the action potential duration in atrial fibrillation (AF) alters the intracellular calcium signaling which can be proarrhythmic
2. The alterations in intracellular calcium signaling affect the nuclear calcium signaling which induces the activation of specific calcium-dependent transcription pathways in AF
Ethics approval(s)Medical Ethics Committee of AZM, Maastricht Hospital, pending as of 28/05/2010
Health condition(s) or problem(s) studiedCardiac atrial fibrillation
InterventionBiopsies of right atrial appendages in patients in SR, with paroxysmal and persistent AF and undergoing for open chest surgery.
Intervention typeOther
Primary outcome measureMeasured on day of biopsy:
1. To study the intracellular calcium alterations in human paroxysmal and persistent AF and the proarrhythmic effects of these alterations in comparison to SR
2. To study the nuclear calcium signaling in human paroxysmal and persistent AF in comparison to SR
3. To determine the Ca2+-dependent transcription pathways activated in AF and to study the consequences of the inactivation of these pathways on atrial cell electrical properties (i.e. AP, currents) and function (contraction)
Secondary outcome measuresMeasured on day of biopsy:
1. To determine the type of intracellular Ca2+ signals which can trigger cellular arrhythmias
2. To determine the key elements which play a major role in the activated calcium-dependent transcription pathways for drug targets
3. Long term goals: to restore contraction in AF and to prevent thrombosis
Overall study start date01/08/2010
Completion date31/01/2015

Eligibility

Participant type(s)Patient
Age groupAdult
Lower age limit18 Years
SexBoth
Target number of participants570
Key inclusion criteria1. Patients applying to the predefined groups
2. Patients have given written consent
3. Both women and men between 18 years (included) and 70 years (included) old
Key exclusion criteria1. Patients who are scheduled for re-operation
2. Patients who do not speak/understand Dutch
3. Patients with sick sinus syndrome, atrioventricular (AV)-block or internal pacemaker
4. Patients who are not will-competent
Date of first enrolment01/08/2010
Date of final enrolment31/01/2015

Locations

Countries of recruitment

  • Netherlands

Study participating centre

Maastricht University
Maastricht
6200 MD
Netherlands

Sponsor information

Maastricht University (Netherlands)
University/education

Cardiovascular Research Institute Maastricht (CARIM)
Department of Physiology
Universiteitssingel 50, Room 3.112
PO Box 616
Maastricht
6200 MD
Netherlands

Website http://www.maastrichtuniversity.nl
ROR logo "ROR" https://ror.org/02jz4aj89

Funders

Funder type

Research organisation

Fondation LEDUCQ (France)
Private sector organisation / Trusts, charities, foundations (both public and private)
Alternative name(s)
Leducq Foundation
Location
France

Results and Publications

Intention to publish date
Individual participant data (IPD) Intention to shareNo
IPD sharing plan summaryNot provided at time of registration
Publication and dissemination planNot provided at time of registration
IPD sharing plan

Editorial Notes

29/05/2020: No publications found.
30/05/2019: Internal review.